JIAN YUN LI-WEI: Open Payments
NPI 1326755737 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,108 in 27 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $31 · 2025 $1,108
Food & beverage: $1,108
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $345 |
| Amgen Inc. | 6 | $320 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $175 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Philips North America LLC | 3 | $68 |
| Esperion Therapeutics, Inc. | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Phadia US Inc. | 1 | $20 |
Products named: LINZESS, EVENITY, XIFAXAN, TRELEGY ELLIPTA, Vest Therapy Und, NEXLETOL, FARXIGA, ImmunoCAP.
Industry payments across NY — which companies pay providers there.
